Diagnosis, management and screening of early localised prostate cancer.
暂无分享,去创建一个
J. Donovan | D. Gillatt | J. Coast | A. Faulkner | S. Selley | Sara Selley
[1] P C Prorok,et al. A national cancer institute sponsored screening trial for prostatic, lung, colorectal, and ovarian cancers , 2010, Cancer.
[2] R. Kane,et al. The relationship of prostate‐specific antigen to digital rectal examination and transrectal ultrasonography: Findings of the American cancer society national prostate cancer detection project , 2010, Cancer.
[3] F. Hamdy,et al. Screening for Prostate Cancer , 2006 .
[4] L. Denis,et al. The European randomized study of screening for prostate cancer , 1997, Cancer.
[5] J. Fricker. Ejaculation raises PSA levels , 1996, The Lancet.
[6] J. Niloff,et al. Cancer of the uterine cervix. , 1996, The New England journal of medicine.
[7] T. Peters,et al. The ICS-'BPH' Study: the psychometric validity and reliability of the ICSmale questionnaire. , 1996, British journal of urology.
[8] J. Ward,et al. Screening for prostate cancer: the case against , 1996, The Medical journal of Australia.
[9] E. Jonsson,et al. Neglected aspects of false positive findings of mammography in breast cancer screening: analysis of false positive cases from the Stockholm trial , 1996, BMJ.
[10] C Parkes,et al. Prospective observational study to assess value of prostate specific antigen as screening test for prostate cancer , 1995, BMJ.
[11] W. Catalona,et al. Surgical management of prostate cancer , 1995, Cancer.
[12] H. Yamanaka,et al. Diagnostic significance of prostate specific antigen and the development of a mass screening system for prostate cancer. , 1995, The Journal of urology.
[13] Budenholzer Br. Prostate-specific antigen testing to screen for prostate cancer. , 1995 .
[14] K. Schwartz,et al. Prostate-specific antigen in a community screening program. , 1995, The Journal of family practice.
[15] C. Mueller,et al. Screening mammography and public health policy: the need for perspective , 1995, The Lancet.
[16] S. Cantor,et al. Prostate cancer screening: a decision analysis. , 1995, The Journal of family practice.
[17] A. Diokno,et al. Are pelvic computed tomography, bone scan and pelvic lymphadenectomy necessary in the staging of prostatic cancer? , 1995, British journal of urology.
[18] K. Kopecky,et al. Color Doppler flow imaging for deep venous thrombosis screening in patients undergoing pelvic lymphadenectomy and radical retropubic prostatectomy for prostatic carcinoma. , 1995, The Journal of urology.
[19] U. Norming,et al. Cost‐effectiveness analysis in early detection of prostate cancer: An evaluation of six screening strategies in a randomly selected population of 2,400 men , 1995, The Prostate.
[20] K. Rosenzweig,et al. Prostate specific antigen following radiotherapy for local prostate cancer. , 1995, The Journal of urology.
[21] D. Kuban,et al. Potential benefit of improved local tumor control in patients with prostate carcinoma , 1995, Cancer.
[22] J. Fracchia,et al. PSA‐detected prostate cancer: Contrasts with palpable disease , 1995, Journal of surgical oncology.
[23] T. Theorell,et al. Psychological reactions in men screened for prostate cancer. , 1995, British journal of urology.
[24] M. Dimopoulos,et al. The value of prostatic specific antigen in the early diagnosis of prostatic cancer: a Greek view. , 1995, British journal of urology.
[25] J. Adolfsson,et al. Decreased sexual capacity after external radiation therapy for prostate cancer impairs quality of life. , 1995, International journal of radiation oncology, biology, physics.
[26] R G Aarnink,et al. Computerized analysis of transrectal ultrasonography images in the detection of prostate carcinoma. , 1995, British journal of urology.
[27] J. Dickinson,et al. General practitioners' attitudes to screening for prostate and testicular cancers , 1995, The Medical journal of Australia.
[28] Philippe E. Zimmern,et al. Nerve‐sparing radical retropubic prostatectomy for localized prostate cancer. The pros and cons , 1995 .
[29] N Urban,et al. Stage, age, comorbidity, and direct costs of colon, prostate, and breast cancer care. , 1995, Journal of the National Cancer Institute.
[30] D. Gillatt,et al. What is the 'normal range' for prostate-specific antigen? Use of a receiver operating characteristic curve to evaluate a serum marker. , 1995, British journal of urology.
[31] P. Carroll,et al. The use and accuracy of cross-sectional imaging and fine needle aspiration cytology for detection of pelvic lymph node metastases before radical prostatectomy. , 1995, The Journal of urology.
[32] A. Partin,et al. Deoxyribonucleic acid ploidy analysis as a predictor of recurrence following radical prostatectomy for stage T2 disease. , 1995, The Journal of urology.
[33] G P Murphy,et al. Report of the consensus workshop on screening and global strategy for prostate cancer , 1995, Cancer.
[34] J. Oesterling,et al. Serum prostate-specific antigen in a community-based population of healthy Japanese men: lower values than for similarly aged white men. , 1995, British journal of urology.
[35] E. Diamandis,et al. Measurement of serum prostate specific antigen levels in women and in prostatectomized men with an ultrasensitive immunoassay technique. , 1995, The Journal of urology.
[36] Jill,et al. Effect of digital rectal examination on serum prostate-specific antigen in a primary care setting. The Internal Medicine Clinic Research Consortium. , 1995, Archives of internal medicine.
[37] J. Epstein,et al. Diagnostic criteria of limited adenocarcinoma of the prostate on needle biopsy. , 1995, Human pathology.
[38] D. Kuban,et al. Carcinoma of the prostate: race as a prognostic indicator in definitive radiation therapy. , 1995, Radiology.
[39] M. Hunt,et al. Localized prostate cancer treated by external-beam radiotherapy alone: serum prostate-specific antigen--driven outcome analysis. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[40] O. Nativ,et al. Radical retropubic prostatectomy in the treatment of localized prostate cancer: experience with 100 consecutive cases. , 1995, Israel journal of medical sciences.
[41] S. Narod,et al. The impact of family history on early detection of prostate cancer , 1995, Nature Medicine.
[42] A. Threlfall,et al. Is the three year breast screening interval too long? Occurrence of interval cancers in NHS breast screening programme's north western region , 1995, BMJ.
[43] P. Lange. New information about prostate-specific antigen and the paradoxes of prostate cancer. , 1995, JAMA.
[44] M. Stampfer,et al. A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer. , 1995, JAMA.
[45] C. Croce,et al. Molecular characterization of prostate-specific antigen messenger RNA expressed in breast tumors. , 1994, Cancer research.
[46] L. Holmberg,et al. Five year follow-up after radical prostatectomy for localized prostate cancer--a study of the impact of different tumor variables on progression. , 1994, Scandinavian journal of urology and nephrology.
[47] W P Evans,et al. The use of prostate specific antigen density to improve the sensitivity of prostate specific antigen in detecting prostate carcinoma , 1994, Cancer.
[48] S. Fisher,et al. Directed and random biopsies of the prostate: indications based on combined results of transrectal sonography and prostate-specific antigen density determinations. , 1994, AJR. American journal of roentgenology.
[49] E. Crawford,et al. Prostate specific antigen density in patients with histologically proven prostate carcinoma , 1994, Cancer.
[50] R. B. Smith,et al. The incidence and significance of detectable levels of serum prostate specific antigen after radical prostatectomy. , 1994, The Journal of urology.
[51] A. Zietman,et al. Treatment related sequelae following external beam radiation for prostate cancer: a review with an update in patients with stages T1 and T2 tumor. , 1994, The Journal of urology.
[52] J. Beck,et al. A critique of the decision analysis for clinically localized prostate cancer. , 1994, The Journal of urology.
[53] P. Scardino,et al. Can radical prostatectomy alter the progression of poorly differentiated prostate cancer? , 1994, The Journal of urology.
[54] E. Klein,et al. Early hospital discharge after radical retropubic prostatectomy: impact on cost and complication rate. , 1994, Urology.
[55] P C Prorok,et al. Prostate cancer screening in the prostate, lung, colorectal and ovarian cancer screening trial of the National Cancer Institute. , 1994, The Journal of urology.
[56] W. Catalona,et al. Early complications of contemporary anatomical radical retropubic prostatectomy. , 1994, The Journal of urology.
[57] T. Wilt,et al. The Prostate Cancer Intervention Versus Observation Trial: a randomized trial comparing radical prostatectomy versus expectant management for the treatment of clinically localized prostate cancer. , 1994, The Journal of urology.
[58] W. Catalona,et al. The nature of prostate cancer detected through prostate specific antigen based screening. , 1994, The Journal of urology.
[59] J. Oesterling,et al. Long-term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer. , 1994, The Journal of urology.
[60] A. Partin,et al. Cancer control and quality of life following anatomical radical retropubic prostatectomy: results at 10 years. , 1994, The Journal of urology.
[61] J. Kabalin. Treatment of post-prostatectomy stress urinary incontinence with periurethral polytetrafluoroethylene paste injection. , 1994, The Journal of urology.
[62] P. Walsh,et al. Radical prostatectomy for impalpable prostate cancer: the Johns Hopkins experience with tumors found on transurethral resection (stages T1A and T1B) and on needle biopsy (stage T1C). , 1994, The Journal of urology.
[63] A. Zietman,et al. Radical prostatectomy and radical radiation therapy for clinical stages T1 to 2 adenocarcinoma of the prostate: new insights into outcome from repeat biopsy and prostate specific antigen followup. , 1994, The Journal of urology.
[64] W. Shipley,et al. Early prostate cancer: the national results of radiation treatment from the Patterns of Care and Radiation Therapy Oncology Group studies with prospects for improvement with conformal radiation and adjuvant androgen deprivation. , 1994, The Journal of urology.
[65] C. Begg. Methodological issues in studies of the treatment, diagnosis, and etiology of prostate cancer. , 1994, Seminars in oncology.
[66] W. Whitmore,et al. Expectant management of clinically localized prostatic cancer. , 1994, The Journal of urology.
[67] W. Catalona,et al. Rate of change in serum prostate specific antigen levels as a method for prostate cancer detection. , 1994, The Journal of urology.
[68] S. Goldenberg,et al. Systematic transrectal ultrasound-guided biopsy of the prostate. , 1994, Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes.
[69] P. Narayan,et al. Utility of preoperative serumprostate-specific antigen concentration and biopsy Gleason score in predicting risk of pelvic lymph node metastases in prostate cancer , 1994 .
[70] M. Benson,et al. Prostate specific antigen and prostate specific antigen density. Roles in patient evaluation and management , 1994, Cancer.
[71] P. Perrin,et al. Positive margins and residual disease following radical prostatectomy: prediction and therapy , 1994 .
[72] R. Kane,et al. Relative sensitivity and specificity of serum prostate specific antigen (PSA) level compared with age‐referenced PSA, PSA density, and PSA change , 1994, Cancer.
[73] E. Messing,et al. Sequelae of radical prostatectomy. , 1994, British journal of urology.
[74] H. Lepor,et al. Detection of prostate cancer in males with prostatism , 1994, The Prostate.
[75] S. Cotton,et al. Voluntary Screening Program for Prostate Cancer: Detection Rate and Cost , 1994, Southern medical journal.
[76] J. Austoker. Cancer Prevention in Primary Care: Screening for ovarian, prostatic, and testicular cancers , 1994, BMJ.
[77] P. Remington,et al. Trends in the surgical treatment of prostate cancer in Wisconsin, 1989-1991. , 1994, Journal of the National Cancer Institute.
[78] R. Kirby,et al. Screening for carcinoma of the prostate: a GP based study. , 1994, British journal of urology.
[79] A. Partin,et al. Small high grade adenocarcinoma of the prostate in radical prostatectomy specimens performed for nonpalpable disease: pathogenetic and clinical implications. , 1994, The Journal of urology.
[80] J. Cummings,et al. The value of laparoscopic lymphadenectomy in conjunction with radical perineal or retropubic prostatectomy. , 1994, The Journal of urology.
[81] L. Kolonel,et al. Animal Fat Consumption and Prostate Cancer: A Prospective Study in Hawaii , 1994, Epidemiology.
[82] I. Powell. Early detection issues of prostate cancer in African American men. , 1994, In vivo.
[83] Goodman Ac,et al. Costs and benefits of prostate cancer screening. Investigators of the American Cancer Society--National Prostate Cancer Detection Project. , 1994 .
[84] Pontes Je. Methods of early detection of prostate cancer: the role of prostatic specific antigen, transrectal ultrasound and digital rectal examination. , 1994 .
[85] G. Murphy,et al. Trends in treatment of localized prostate cancer by radical prostatectomy: observations from the Commission on Cancer National Cancer Database, 1985-1990. , 1994, Urology.
[86] M. Resnick,et al. Laparoscopic pelvic lymphadenectomy and radical perineal prostatectomy: a viable alternative to radical retropubic prostatectomy. , 1994, The Journal of urology.
[87] A. Melman,et al. Combined laparoscopic pelvic lymph node dissection and modified belt radical perineal prostatectomy for localized prostatic adenocarcinoma. , 1994, Urology.
[88] C. Nodine,et al. Follow-up of benign hypoechoic peripheral zone lesions of the prostate gland: US characteristics and cancer prevalence. , 1994, Radiology.
[89] H. Winfield,et al. Comparative financial analysis of laparoscopic versus open pelvic lymph node dissection for men with cancer of the prostate. , 1994, The Journal of urology.
[90] H. Herr,et al. Quality of life of incontinent men after radical prostatectomy. , 1994, The Journal of urology.
[91] F. Grodstein,et al. Prospective study of plasma fatty acids and risk of prostate cancer. , 1994, Journal of the National Cancer Institute.
[92] P. Walsh,et al. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. , 1994, JAMA.
[93] R. Hautmann,et al. Radical retropubic prostatectomy: morbidity and urinary continence in 418 consecutive cases. , 1994, Urology.
[94] J. Johansson. Watchful waiting for early stage prostate cancer. , 1994, Urology.
[95] D. McCullough,et al. Correlation of prostate-specific antigen and prostate-specific antigen density with outcome of prostate biopsy. , 1994, Urology.
[96] E. Greenberg,et al. Changes in prostate cancer incidence and treatment in USA , 1994, The Lancet.
[97] R. Thisted,et al. Results of conservative management of clinically localized prostate cancer. , 1994, The New England journal of medicine.
[98] K. Tveter,et al. [Clinical significance of prostate-specific antigen]. , 1994, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.
[99] E. Harkness,et al. Cancer incidence in a population potentially exposed to radium-226 at Dalgety Bay, Scotland. , 1994, British Journal of Cancer.
[100] J. Ramon,et al. Morbidity of radical retropubic prostatectomy following previous prostate resection , 1994, Journal of surgical oncology.
[101] J. Epstein. Discrepancies between findings suspicious for prostate cancer at rectal examination and benign biopsy findings. , 1993, Radiology.
[102] C. Mettlin. Early detection of prostate cancer following repeated examinations by multiple modalities: results of the American Cancer Society National Prostate Cancer Detection Project. , 1993, Clinical and investigative medicine. Medecine clinique et experimentale.
[103] H. C. Graves,et al. Standardization of immunoassays for prostate‐specific antigen. A problem of prostate‐specific antigen complexation or a problem of assay design? , 1993, Cancer.
[104] P. Carroll,et al. Selection of patients for laparoscopic pelvic lymphadenectomy prior to radical prostatectomy: a decision analysis. , 1993, Urology.
[105] B. Yankaskas,et al. Diagnosis of prostatic carcinoma: value of random transrectal sonographically guided biopsies. , 1993, AJR. American journal of roentgenology.
[106] R. Peschel,et al. Radiation therapy for prostate cancer long‐term results and implications for future advances , 1993, Cancer.
[107] J. Oesterling,et al. Influence of patient age on the serum PSA concentration. An important clinical observation. , 1993, The Urologic clinics of North America.
[108] P C Prorok,et al. Prostate Cancer Screening: What We Know and What We Need To Know , 1993, Annals of Internal Medicine.
[109] M. Benson,et al. PSA density (PSAD). Role in patient evaluation and management. , 1993, The Urologic clinics of North America.
[110] J. Smith,et al. Future directions in tumor marker technology for prostate cancer. , 1993, The Urologic clinics of North America.
[111] W. Lees,et al. Prostate cancer and the role of color Doppler US. , 1993, Radiology.
[112] G. Zagars. The prognostic significance of a single serum prostate-specific antigen value beyond six months after radiation therapy for adenocarcinoma of the prostate. , 1993, International journal of radiation oncology, biology, physics.
[113] W. Catalona,et al. Return of erections and urinary continence following nerve sparing radical retropubic prostatectomy. , 1993, The Journal of urology.
[114] A. Morey,et al. The effects of exercise and activity on serum prostate specific antigen levels. , 1993, The Journal of urology.
[115] T. Beaty,et al. Hereditary prostate cancer: epidemiologic and clinical features. , 1993, The Journal of urology.
[116] R. Kane,et al. Characteristics of prostate cancers detected in a multimodality early detection program , 1993 .
[117] W. Catalona,et al. Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening. , 1993, JAMA.
[118] A. Stenwig,et al. Prognosis of localised prostatic cancer managed by "watch and wait" policy. , 1993, British journal of urology.
[119] F. Li,et al. Molecular epidemiology studies of cancer in families. , 1993, British Journal of Cancer.
[120] W. Ellis,et al. The inability of prostate specific antigen index to enhance the predictive the value of prostate specific antigen in the diagnosis of prostatic carcinoma. , 1993, The Journal of urology.
[121] J. O'donoghue,et al. A reappraisal of serial isotope bone scans in prostate cancer. , 1993, The British journal of radiology.
[122] S. Viswanath,et al. Routine estimation of prostate specific antigen prior to clinic attendance in patients with symptoms of bladder outlet obstruction. , 1993, British journal of urology.
[123] Li Fp. Molecular epidemiology studies of cancer in families. , 1993 .
[124] C. Perez,et al. Technical and tumor-related factors affecting outcome of definitive irradiation for localized carcinoma of the prostate. , 1993, International journal of radiation oncology, biology, physics.
[125] S. Golding,et al. Staging prostatic cancer. , 1993, Clinical radiology.
[126] O. Nilsson,et al. Serum prostate specific antigen complexed to alpha 1-antichymotrypsin as an indicator of prostate cancer. , 1993, The Journal of urology.
[127] D. Chan,et al. The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. , 1993, The Journal of urology.
[128] R. Vessella,et al. Screening for prostatic carcinoma with prostate specific antigen: results of the second year. , 1993, The Journal of urology.
[129] Galina Pizov,et al. Correlation of pathologic findings with progression after radical retropubic prostatectomy , 1993, Cancer.
[130] A W Partin,et al. Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of followup. , 1993, The Journal of urology.
[131] C. Catton,et al. Carcinoma of the prostate: results of radical radiotherapy (1970-1985). , 1993, International journal of radiation oncology, biology, physics.
[132] K. Pienta,et al. Risk Factors for Prostate Cancer , 1993, Annals of Internal Medicine.
[133] C. Dinney,et al. Diagnostic testing for prostate cancer detection: less is best. , 1993, Urology.
[134] A. Goodman,et al. The benefit and cost of prostate cancer early detection , 1993, CA: a cancer journal for clinicians.
[135] K. Convery,et al. Age‐race Interaction in Prostatic Adenocarcinoma Treated with External Beam Irradiation , 1993, American journal of clinical oncology.
[136] P. Humphrey,et al. Is prostate specific antigen of clinical importance in evaluating outcome after radical prostatectomy. , 1993, The Journal of urology.
[137] D. Schapira,et al. Prostate-cancer surveillance - a cost-effective strategy. , 1993, International journal of oncology.
[138] F. Speizer,et al. A retrospective cohort study of vasectomy and prostate cancer in US men. , 1993, JAMA.
[139] K. German,et al. Dangers of long waiting times for outpatient appointments at a urology clinic. , 1993, BMJ.
[140] M. Rifkin,et al. Prostate: techniques, results, and potential applications of color Doppler US scanning. , 1993, Radiology.
[141] J. Oesterling,et al. The use of prostate-specific antigen in staging patients with newly diagnosed prostate cancer. , 1993, JAMA.
[142] A. Espeland,et al. Inability of Refined CT to Assess Local Extent of Prostatic Cancer , 1993, Acta radiologica.
[143] U. Norming,et al. Diagnostic methods in the detection of prostate cancer: a study of a randomly selected population of 2,400 men. , 1992, The Journal of urology.
[144] N F Wasserman,et al. Preoperative assessment of prostatic carcinoma by computerized tomography. Weaknesses and new perspectives. , 1992, Urology.
[145] R. Vessella,et al. Evaluation of the Abbott IMx automated immunoassay of prostate-specific antigen. , 1992, Clinical chemistry.
[146] B Castelain,et al. Prostate cancer treated by radiotherapy: a multivariate study. , 1992, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[147] A. Steinfeld. Questions regarding the treatment of localized prostate cancer. , 1992, Radiology.
[148] M. Terris,et al. Detection of clinically significant prostate cancer by transrectal ultrasound-guided systematic biopsies. , 1992, The Journal of urology.
[149] N. Green,et al. Prostate cancer--the impact of irradiation on urinary outlet obstruction. , 1992, British journal of urology.
[150] B. Wen,et al. Results of radical perineal prostatectomy with adjuvant brachytherapy. , 1992, Radiology.
[151] P. Scardino,et al. Frequency and location of extracapsular extension and positive surgical margins in radical prostatectomy specimens. , 1992, The Journal of urology.
[152] D. Siders,et al. Predicted prostate specific antigen results using transrectal ultrasound gland volume. Differentiation of benign prostatic hyperplasia and prostate cancer , 1992, Cancer.
[153] Srinivasan Vijayakumar,et al. Localized prostate cancer: use of serial prostate-specific antigen measurements during radiation therapy. , 1992, Radiology.
[154] D. Beyer,et al. Guided brachytherapy for treatment of confined prostate cancer. , 1992, Urology.
[155] G. Jones. Prospective, conservative management of localized prostate cancer , 1992, Cancer.
[156] M. Siroky,et al. The role of fine‐needle aspiration biopsy of the prostate in staging adenocarcinoma , 1992, Cancer.
[157] W. Catalona,et al. Lower incidence of unsuspected lymph node metastases in 521 consecutive patients with clinically localized prostate cancer. , 1992, The Journal of urology.
[158] A. Shanberg,et al. Temporary iridium‐192 implant in the management of carcinoma of the prostate , 1992, Cancer.
[159] J. Oesterling,et al. Prostate-specific antigen. Improving its ability to diagnose early prostate cancer. , 1992, JAMA.
[160] L. Holmberg,et al. High 10-year survival rate in patients with early, untreated prostatic cancer. , 1992, JAMA.
[161] E. Metter,et al. Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease. , 1992, JAMA.
[162] M. Benson,et al. The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen. , 1992, The Journal of urology.
[163] J. Dekernion,et al. Detection of local recurrence after radical prostatectomy by prostate specific antigen and transrectal ultrasound. , 1992, The Journal of urology.
[164] S. Golding,et al. CT evaluation of lymph node status at presentation of prostatic carcinoma. , 1992, The British journal of radiology.
[165] W. Catalona. Radical surgery for advanced prostate cancer and for radiation failures. , 1992, The Journal of urology.
[166] R. B. Smith,et al. Prostate specific antigen levels after radical prostatectomy in patients with organ confined and locally extensive prostate cancer. , 1992, The Journal of urology.
[167] J. Goméz,et al. Serum prostate specific antigen as pre-screening test for prostate cancer. , 1992, The Journal of urology.
[168] W. Catalona,et al. Effects of rectal examination, prostatic massage, ultrasonography and needle biopsy on serum prostate specific antigen levels. , 1992, The Journal of urology.
[169] J. Eble,et al. The roles of fine needle aspiration and needle core biopsies in the diagnosis of primary prostatic cancer. , 1992, Human pathology.
[170] D. Paulson,et al. Radical prostatectomy: the pros and cons of the perineal versus retropubic approach. , 1992, The Journal of urology.
[171] E. Blight. Seeding of prostate adenocarcinoma following transrectal needle biopsy. , 1992, Urology.
[172] A. Ghiatas,et al. Systematic transrectal ultrasound guided prostate biopsy after negative digitally directed prostate biopsy. , 1992, The Journal of urology.
[173] T. Stamey,et al. The predictive significance of substaging stage A prostate cancer (A1 versus A2) for volume and grade of total cancer in the prostate. , 1992, The Journal of urology.
[174] T. Stamey,et al. Predictive value of contralateral biopsies in unilaterally palpable prostate cancer. , 1992, The Journal of urology.
[175] J. Drago,et al. Prostate‐specific antigen, digital rectal examination, and transrectal ultrasound in predicting the probability of cancer , 1992, Journal of surgical oncology.
[176] I. Kaplan,et al. The importance of local control in the treatment of prostatic cancer. , 1992, The Journal of urology.
[177] J. Ramon,et al. Radical retropubic prostatectomy: morbidity and quality of life. Experience with 620 consecutive cases. , 1992, The Journal of urology.
[178] M. Terris,et al. Estimation of prostate cancer volume by transrectal ultrasound imaging. , 1992, The Journal of urology.
[179] J. Adolfsson,et al. Deferred treatment in clinically localised prostatic carcinoma. , 1992, British journal of urology.
[180] Stage B Adenocarcinoma of the Prostate: Transrectal US and Pathologic Correlation of Nonmalignant Hypoechoic Peripheral Zone Lesions , 1992 .
[181] P. Scardino,et al. The frequency and morbidity of local tumor recurrence after definitive radiotherapy for stage C prostate cancer. , 1991, The Journal of urology.
[182] D. Prapotnich,et al. Systematic prostatic biopsies in 100 men with no suspicion of cancer on digital rectal examination. , 1991, The Journal of urology.
[183] R. Joseph Babaian,et al. The role of prostate‐specific antigen as part of the diagnostic triad and as a guide when to perform a biopsy , 1991, Cancer.
[184] M. Spitz,et al. Familial patterns of prostate cancer: a case-control analysis. , 1991, The Journal of urology.
[185] M. Blute,et al. Radical prostatectomy for stage A adenocarcinoma of the prostate: staging errors and their implications for treatment recommendations and disease outcome. , 1991, The Journal of urology.
[186] T. P. Cooper,et al. Prostatic needle biopsy using an Iowa trumpet biopsy needle guide during standard digital rectal examination: a comparison with ultrasound controlled biopsy. , 1991, The Journal of urology.
[187] S. Clejan,et al. Prostate cancer screening in younger men: prostate-specific antigen and public awareness. , 1991, Urology.
[188] R. Fiorelli,et al. Early detection of stage A prostate carcinoma: combined use of prostate-specific antigen and transrectal ultrasonography. , 1991, The Journal of the American Osteopathic Association.
[189] M. Devonec,et al. Screening for prostate cancer. Comparison of transrectal ultrasound, prostate specific antigen and rectal examination. , 1991, British journal of urology.
[190] G. Zagars,et al. Complications following external beam radiation therapy for prostate cancer: an analysis of patients treated with and without staging pelvic lymphadenectomy. , 1991, The Journal of urology.
[191] L. Brady,et al. External beam irradiation versus 125 iodine implant in the definitive treatment of prostate carcinoma. , 1991, International journal of radiation oncology, biology, physics.
[192] E. Hammond,et al. Long-term follow-up after radical prostatectomy. Identification of prognostic variables. , 1991, The Urologic clinics of North America.
[193] J. Kelley,et al. Digitally-directed transrectal biopsy using Biopty gun versus transrectal needle aspiration: comparison of diagnostic yield and comfort. , 1991, Urology.
[194] Y. Reinberg,et al. Long-term followup results after expectant management of stage A1 prostatic cancer. , 1991, The Journal of urology.
[195] W. Catalona,et al. The ability of systematic transrectal ultrasound guided biopsy to detect prostate cancer in men with the clinical diagnosis of benign prostatic hyperplasia. , 1991, The Journal of urology.
[196] P. Walsh,et al. Cancer control following anatomical radical prostatectomy: an interim report. , 1991, The Journal of urology.
[197] M. D. Allen,et al. Biopsy of the prostate guided by transrectal ultrasonography: early experience in a teaching community hospital. , 1991, Southern medical journal.
[198] P. Walsh,et al. Needle biopsy associated tumor tracking of adenocarcinoma of the prostate. , 1991, The Journal of urology.
[199] P. Walsh,et al. Sexual function following radical prostatectomy: influence of preservation of neurovascular bundles. , 1991, The Journal of urology.
[200] M. Terris,et al. Determination of prostate volume by transrectal ultrasound. , 1991, The Journal of urology.
[201] W. Catalona,et al. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. , 1991, The New England journal of medicine.
[202] M. Rifkin,et al. Palpable masses in the prostate: superior accuracy of US-guided biopsy compared with accuracy of digitally guided biopsy. , 1991, Radiology.
[203] J. Adolfsson,et al. Comparison of transrectal prostate digital aspiration and ultrasound-guided core biopsies in 99 men. , 1991, Urology.
[204] P. Narayan,et al. Core biopsy instrument in the diagnosis of prostate cancer: superior accuracy to fine needle aspiration. , 1991, The Journal of urology.
[205] G. Chodak,et al. Routine screening for cancer of the prostate. , 1991, Journal of the National Cancer Institute.
[206] R. Clements,et al. "State of the art" transrectal ultrasound imaging in the assessment of prostatic disease. , 1991, The British journal of radiology.
[207] S. Loening,et al. Radical prostatectomy and adjuvant radioactive gold seed placement: results of treatment at 5 and 10 years for clinical stages A2, B1 and B2 cancer of the prostate. , 1991, The Journal of urology.
[208] I. Thompson,et al. Expectant management of localized prostatic cancer , 1991, Cancer.
[209] E A Zerhouni,et al. Nonpalpable prostate cancer: detection with MR imaging. , 1991, Radiology.
[210] R. Gittes. Carcinoma of the prostate. , 1991, The New England journal of medicine.
[211] A. Fleischer,et al. New developments in transrectal sonography of the prostate. , 1990, Current opinion in radiology.
[212] E. Varenhorst,et al. Costs and benefits of early detection of prostatic cancer. , 1990, Health policy.
[213] A. Miller,et al. Report on a workshop of the UICC project on evaluation of screening for cancer , 1990, International journal of cancer.
[214] J. Moul,et al. Radical prostatectomy for clinical stage T1-2N0M0 prostatic adenocarcinoma: long-term results. , 1990, The Journal of urology.
[215] I M Thompson,et al. Economics of screening for carcinoma of the prostate. , 1990, The Urologic clinics of North America.
[216] W. Whitmore. Natural history of low-stage prostatic cancer and the impact of early detection. , 1990, The Urologic clinics of North America.
[217] C. Perez,et al. Carcinoma of the prostate stage B and C: lack of influence of duration of radiotherapy on tumor control and treatment morbidity. , 1990, International journal of radiation oncology, biology, physics.
[218] N. Green,et al. Prostate cancer: post-irradiation incontinence. , 1990, The Journal of urology.
[219] A. Toi,et al. Value of random US-guided transrectal prostate biopsy. , 1990, Radiology.
[220] W. Cooner,et al. Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen. , 1990, The Journal of urology.
[221] P Carlsson,et al. Screening for carcinoma of the prostate by digital rectal examination in a randomly selected population. , 1990, BMJ.
[222] P. Mouriquand,et al. The significance of the prostatic hypoechoic area: results in 226 ultrasonically guided prostatic biopsies. , 1990, The Journal of urology.
[223] T. Therneau,et al. Pattern of failure after radical retropubic prostatectomy for clinically and pathologically localized adenocarcinoma of the prostate: influence of tumor deoxyribonucleic acid ploidy. , 1989, The Journal of urology.
[224] J. Dekernion,et al. Early post-operative morbidity of total prostatectomy. , 1989, British journal of urology.
[225] C. Powell,et al. Prostate specific antigen--a screening test for prostatic cancer? , 1989, British journal of urology.
[226] G. Chodak. Early detection and screening for prostatic cancer. , 1989, Urology.
[227] T. Marteau,et al. Psychological costs of screening. , 1989, BMJ.
[228] J. Drago,et al. Use of transrectal ultrasound in detection of prostatic carcinoma: A preliminary report , 1989, Journal of surgical oncology.
[229] J. Moul,et al. Risk factors for perineal seeding of prostate cancer after needle biopsy. , 1989, The Journal of urology.
[230] P. Scardino,et al. The appearance of prostate cancer on transrectal ultrasonography: correlation of imaging and pathological examinations. , 1989, The Journal of urology.
[231] T. Stamey,et al. Ultrasound guided transrectal core biopsies of the palpably abnormal prostate. , 1989, The Journal of urology.
[232] M. Terris,et al. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. , 1989, The Journal of urology.
[233] G. Chodak,et al. Assessment of screening for prostate cancer using the digital rectal examination. , 1989, The Journal of urology.
[234] P. Narayan,et al. A comparison of fine needle aspiration and core biopsy in diagnosis and preoperative grading of prostate cancer. , 1989, The Journal of urology.
[235] D. Siders,et al. Transrectal ultrasound in the diagnosis and staging of prostatic carcinoma. , 1989, Radiology.
[236] A. Morenas,et al. Expanded role for fine needle aspiration of the prostate. A study of 335 specimens , 1989, Cancer.
[237] M. Rifkin,et al. Echogenicity of prostate cancer correlated with histologic grade and stromal fibrosis: endorectal US studies. , 1989, Radiology.
[238] R. Sylvester,et al. TNM classification of genitourinary tumours 1987--position of the EORTC Genitourinary Group. , 1988, British journal of urology.
[239] H. Ragde,et al. Ultrasound-guided prostate biopsy. Biopty gun superior to aspiration. , 1988, Urology.
[240] H. Yamanaka,et al. Clinical characteristics of prostatic cancer detected by mass screening , 1988, The Prostate.
[241] S. Torp-Pedersen,et al. Early prostate cancer: diagnostic costs of screening transrectal US and digital rectal examination. , 1988, Radiology.
[242] H Y Kressel,et al. Prostatic carcinoma: staging with MR imaging at 1.5 T. , 1988, Radiology.
[243] S. Torp-Pedersen,et al. Prostate Cancer: Comparison of Transrectal US and Digital Rectal Examination for Screening , 1988, Radiology.
[244] T. Stamey,et al. Morphometric and clinical studies on 68 consecutive radical prostatectomies. , 1988, The Journal of urology.
[245] A. Morenas,et al. Prostatic adenocarcinoma: reproducibility and correlation with clinical stages of four grading systems. , 1988, Human pathology.
[246] M. Rifkin,et al. Implications of Small, Peripheral Hypoechoic Lesions in Endorectal US of the Prostate , 1988, Radiology.
[247] L. Layfield,et al. Use of fine needle aspiration for detection of stage A prostatic carcinoma before transurethral resection of the prostate: a clinical trial. , 1987, The Journal of urology.
[248] G. Friedland. Staging of genitourinary cancers. The role of diagnostic imaging , 1987, Cancer.
[249] M. Spitz,et al. Incidence of prostate cancer and marital status. , 1987, Journal of the National Cancer Institute.
[250] M. Resnick. Transrectal ultrasound guided versus digitally directed prostatic biopsy: a comparative study. , 1987, The Journal of urology.
[251] P. Boyle,et al. Cancer of the prostate: epidemiology and aetiology. , 1987, British journal of urology.
[252] J. W. Segura,et al. Perioperative and postoperative complications from bilateral pelvic lymphadenectomy and radical retropubic prostatectomy. , 1987, The Journal of urology.
[253] P. Guinan,et al. An evaluation of prostate specific antigen in prostatic cancer. , 1987, The Journal of urology.
[254] M. Drummond,et al. Health Care Technology: Effectiveness, Efficiency and Public Policy@@@Methods for the Economic Evaluation of Health Care Programmes , 1988 .
[255] R B Jeffrey,et al. Prostatic carcinoma: staging by clinical assessment, CT, and MR imaging. , 1987, Radiology.
[256] G. Hanks,et al. A comparison of the cost of various treatment methods for early cancer of the prostate. , 1986, International journal of radiation oncology, biology, physics.
[257] P. Walsh,et al. Prognosis of untreated stage A1 prostatic carcinoma: a study of 94 cases with extended followup. , 1986, The Journal of urology.
[258] R. Beart,et al. Trends in patterns of care for prostatic cancer, 1974-1983: results of surveys by the American College of Surgeons. , 1986, The Journal of urology.
[259] H. Watanabe,et al. Comparison of digital examination and transrectal ultrasonography for the diagnosis of prostatic cancer. , 1986, The Journal of urology.
[260] B. Ljung,et al. Fine needle aspiration biopsy of the prostate gland: a study of 103 cases with histological followup. , 1986, The Journal of urology.
[261] J. Koizumi,et al. Fine needle aspiration of the abnormal prostate: a cytohistological correlation. , 1986, The Journal of urology.
[262] D. Fryback,et al. A Cost-Effectiveness Analysis of Screening for Carcinoma of the Prostate by Digital Examination , 1985, Medical decision making : an international journal of the Society for Medical Decision Making.
[263] G. Chodak,et al. Early detection of prostate cancer by routine screening. , 1984, JAMA.
[264] L. Chambers,et al. Assessing the effectiveness of community screening programs. , 1984, JAMA.
[265] W Hinshaw,et al. Radical surgery versus radiotherapy for adenocarcinoma of the prostate. , 1982, The Journal of urology.
[266] C. Roehrborn,et al. Variability of repeated serum prostate-specific antigen (PSA) measurements within less than 90 days in a well-defined patient population. , 1996, Urology.
[267] E. Diamandis,et al. Prostate-specific antigen in milk of lactating women. , 1995, Clinical chemistry.
[268] D. Dearnaley. Radiotherapy of prostate cancer: established results and new developments. , 1995, Seminars in surgical oncology.
[269] J. Fowler,et al. Experience with radical prostatectomy and radiation therapy for localized prostate cancer at a Veterans Affairs Medical Center. , 1995, The Journal of urology.
[270] B. Budenholzer,et al. Prostate-specific antigen testing to screen for prostate cancer. , 1995, The Journal of family practice.
[271] M. Rifkin,et al. Magnetic Resonance Imaging of Prostate Cancer: Update , 1995, Topics in magnetic resonance imaging : TMRI.
[272] H. C. Graves,et al. Nonprostatic sources of prostate-specific antigen: a steroid hormone-dependent phenomenon? , 1995, Clinical chemistry.
[273] G. Kerr,et al. Radical radiotherapy for localized adenocarcinoma of the prostate. A report of 191 cases. , 1995, British journal of urology.
[274] R. Myers. Radical Retropubic Prostatectomy: Balance between Preserving Urinary Continence and Achievement of Negative Margins , 1995 .
[275] D. Newling. European trials and the management of prostate cancer. , 1995, Seminars in surgical oncology.
[276] F. Ménégoz,et al. A recent increase in the incidence of prostatic carcinoma in a French population: role of ultrasonography and prostatic specific antigen. , 1995, European journal of cancer.
[277] J. Muscat,et al. Serum prostate-specific antigen as a predictor of radiographic staging studies in newly diagnosed prostate cancer. , 1995, Cancer Investigation.
[278] D. Triezenberg,et al. Cancer screening and detection in family practice: a MIRNET study. , 1995, The Journal of family practice.
[279] H. Huland,et al. Is a Prediction of Negative Margins and Continence Possible before Radical Prostatectomy , 1995 .
[280] C. Blomqvist,et al. Primary radiation therapy in the treatment of localized prostatic cancer. , 1995, Acta oncologica.
[281] O. Brawley,et al. Geographic, age, and racial variation in the treatment of local/regional carcinoma of the prostate. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[282] D. Grobbee,et al. Volume adjustment for intermediate prostate-specific antigen values in a screening population. , 1995, European journal of cancer.
[283] Smith Ma,et al. Cancer screening and detection in family practice: a MIRNET study. , 1995 .
[284] H. Zincke,et al. Radical retropubic prostatectomy for prostate cancer in the elderly and the young: complications and prognosis. , 1994, European urology.
[285] R. Dillman,et al. Value of prostate cancer screening in a comprehensive community cancer center. , 1994, Cancer investigation.
[286] P. Sieber,et al. The use of prostate specific antigen and prostate specific antigen density in the diagnosis of prostate cancer in a community based urology practice. , 1994, The Journal of urology.
[287] F. Freiha,et al. Utility of preoperative serum prostate-specific antigen concentration and biopsy Gleason score in predicting risk of pelvic lymph node metastases in prostate cancer. , 1994, Urology.
[288] J. Pontes. Methods of early detection of prostate cancer: the role of prostatic specific antigen, transrectal ultrasound and digital rectal examination. , 1994, In vivo.
[289] J. Oesterling,et al. Prostate-specific antigen: concepts for staging prostate cancer and monitoring response to therapy. , 1994, Mayo Clinic proceedings.
[290] J. Oesterling,et al. Measurement of serum prostate specific antigen using IMx prostate specific antigen assay. , 1994, The Journal of urology.
[291] S. Barnes,et al. Soy intake and cancer risk: a review of the in vitro and in vivo data. , 1994, Nutrition and cancer.
[292] H. Huland,et al. Systematic sextant biopsies in 651 patients referred for prostate evaluation. , 1994, The Journal of urology.
[293] M. Naslund,et al. An economic rationale for prostate cancer screening. , 1994, Urology.
[294] M. Soloway,et al. Cigarette smoking: A review of possible associations with benign prostatic hyperplasia and prostate cancer , 1993, The Prostate.
[295] A. Herder,et al. Radical retropubic prostatectomy for localised prostatic carcinoma: a clinical and pathological study of 201 cases. , 1993, Scandinavian journal of urology and nephrology.
[296] C. Stief,et al. Screening for prostatic cancer: the case for. , 1993 .
[297] D. C. Aziz,et al. Prostate‐specific antigen and prostate volume: A meta‐analysis of prostate cancer screening criteria , 1993, Journal of clinical laboratory analysis.
[298] M. Barry,et al. Patient-reported complications and follow-up treatment after radical prostatectomy. The National Medicare Experience: 1988-1990 (updated June 1993). , 1993, Urology.
[299] F. Schröder,et al. Tissue polypeptide-specific antigen: a discriminative parameter between prostate cancer and benign prostatic hypertrophy. , 1993, European journal of cancer.
[300] G. Chisholm,et al. Is the outcome of conservative management for localized prostate cancer acceptable? An overview. , 1993, European urology.
[301] E. Varenhorst,et al. Quality of life after radical retropubic prostatectomy for carcinoma of the prostate. , 1993, European urology.
[302] J. Ramon,et al. Urinary continence following radical retropubic prostatectomy. , 1993, British journal of urology.
[303] J. Oesterling. PSA leads the way for detecting and following prostate cancer. , 1993, Contemporary urology.
[304] P. Boyle,et al. Screening for prostate cancer--necessity or nonsense? , 1993, European journal of cancer.
[305] O. Löfman,et al. Repeated screening for carcinoma of the prostate by digital rectal examination in a randomly selected population. , 1992, Acta oncologica.
[306] M. Anscher,et al. Radiotherapy for prostate cancer: should the seminal vesicles be considered target? , 1992, International journal of radiation oncology, biology, physics.
[307] F. Schröder,et al. The TNM classification of prostate cancer , 1992, The Prostate. Supplement.
[308] K. Jauhiainen,et al. Can fine needle aspiration biopsy detect incidental prostatic carcinoma (T1) prior to TUR? , 1992, European urology.
[309] S. Bigler,et al. Prostate cancer tumor location as predicted by digital rectal examination transferred to ultrasound and ultrasound‐guided prostate needle biopsy , 1992, Journal of cellular biochemistry. Supplement.
[310] H. Schriewer,et al. Influence of prostatic disease and prostatic manipulations on the concentration of prostate-specific antigen. , 1992, European urology.
[311] C. Stidley,et al. Transperineal percutaneous iridium-192 interstitial template implant of the prostate: results and complications in 321 patients. , 1992, International journal of radiation oncology, biology, physics.
[312] M. Lieber. DNA ploidy: Early malignant lesions , 1992, Journal of cellular biochemistry. Supplement.
[313] M. Wirth,et al. Radical prostatectomy for carcinoma of the prostate: long-term follow-up of 115 patients. , 1991, European urology.
[314] P. Chang. Evaluating the role of transrectal ultrasonography and magnetic resonance imaging in prostate carcinoma. , 1991, Current opinion in radiology.
[315] H. Quintens,et al. Radical retropubic prostatectomy: complications and quality of life (429 cases, 1983-1989). , 1991, European urology.
[316] G. Knox,et al. Case-control studies of screening procedures. , 1991, Public health.
[317] P. Lobert,et al. Biologic aggressiveness of palpable and nonpalpable prostate cancer: assessment with endosonography. , 1991, Radiology.
[318] JohannesG. Schmidt,et al. The epidemiology of mass breast cancer screening--a plea for a valid measure of benefit. , 1990, Journal of clinical epidemiology.
[319] H. Davis,et al. External-beam radiation for carcinoma of the prostate. , 1990, European urology.
[320] W. Cooner,et al. Coordination of Urosonography and Prostate-Specific Antigen in the Diagnosis of Nonpalpable Prostate Cancer , 1989 .
[321] D. Siders,et al. Transrectal biopsy of the prostate guided with transrectal US: longitudinal and multiplanar scanning. , 1989, Radiology.
[322] S. Torp-Pedersen,et al. Hypoechoic lesions of the prostate: clinical relevance of tumor size, digital rectal examination, and prostate-specific antigen. , 1989, Radiology.
[323] R. Clements,et al. How accurate is the index finger? A comparison of digital and ultrasound examination of the prostatic nodule. , 1988, Clinical radiology.
[324] H. Hricak. Noninvasive imaging for staging of prostate cancer: magnetic resonance imaging, computed tomography, and ultrasound. , 1988, NCI monographs : a publication of the National Cancer Institute.
[325] M. Bagshaw. External Beam Irradiation of Prostatic Cancer , 1988 .
[326] J. Grups. [Long-term results of radical prostatectomy]. , 1988, Der Urologe. Ausg. A.
[327] T. Ludvigsen,et al. Digital rectal examination to screen for prostatic cancer. , 1988, European urology.
[328] R. Gibbons. Total prostatectomy for clinically localized prostate cancer: long-term surgical results and current morbidity. , 1988, NCI monographs : a publication of the National Cancer Institute.
[329] T. Gasser,et al. Treatment of localized prostatic cancer. Radical prostatectomy versus placebo. A 15-year follow-up. , 1988, Scandinavian journal of urology and nephrology. Supplementum.
[330] J. Mulcahy,et al. Carcinoma of the prostate. , 1978, The Journal of the Kentucky Medical Association.
[331] Ja Wilson,et al. Principles and practice of screening for disease , 1968 .
[332] D. Gleason. Classification of prostatic carcinomas. , 1966, Cancer chemotherapy reports.
[333] A. Proudfoot,et al. CANCER OF THE UTERINE CERVIX , 1957, The Ulster Medical Journal.